Table 1.
Characteristics of study participants, including the IUPM values determined by either the TZA or Q-VOA.
| Participant ID | Age | Current CD4+ T cell count (cells/mm3) | Current ART regimen | Years on ART | Current viral load (copies/mL) | IUPM (TZA) | IUPM (Q-VOA) |
|---|---|---|---|---|---|---|---|
| 001 | 63 | 1,264.0 | TDF+FTC+ATV/r | 15 | <15 | 32.2 | 2.4 |
| 002 | 71 | 509.2 | TDF+FTC+NVP | 12 | <15 | 1.2 | 0.4 |
| 003 | 40 | 850.1 | TDF+FTC+RAL | 5 | <15 | 50.8 | 0.3 |
| 004 | 51 | 859.2 | TDF+FTC+ATV/r | 18 | <15 | 18.4 | 0.5 |
| 005 | 52 | 636.4 | RAL+DRV/r | 14 | <15 | 50.4 | 0.3 |
| 006 | 57 | 859.7 | AZT+3TC+NFV | 14 | <15 | 4.3 | 0.4 |
| 007 | 57 | 389.6 | TDF+FTC+EFV | 17 | <15 | 128.9 | 0.3 |
| 008 | 56 | 510.5 | d4T+ddI+NFV | 17 | <15 | 4.6 | 1.1 |
| 009 | 34 | 797.1 | TDF+FTC+EVG/c | 1 | <15 | 1.5 | 0.5 |
| 010 | 57 | 700.6 | d4T+3TC+EFV | 14 | <15 | 141.7 | 1.1 |
| 011 | 66 | 615.1 | AZT+3TC+EFV | 19 | <15 | NA | 0.8 |
| 012 | 52 | 374.4 | TDF+FTC+ATV/r | 13 | <15 | 7.8 | NA |
| 013 | 59 | 1,586.7 | TDF+RAL+ATV/r | 12 | <15 | NA | 0.3 |
| 014 | 53 | 469.3 | ABC+3TC+RAL | 12 | <15 | 132.6 | NA |
| 015 | 54 | 612.7 | TDF+FTC+EFV | 13 | <15 | 35.3 | NA |
| Mean ± S.D. | 54.8 ± 9.2 | 735.6 ± 329.0 | 13.1 ± 4.7 | <15 | 46.9 ± 52.8 | 0.7 ± 0.6 |